evertex fabrinology limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 511.8 million compared to TWD 602.77 million a year ago. Revenue was TWD 655.22 million compared to TWD 845.15 million a year ago.

Net income was TWD 49.35 million compared to TWD 32.84 million a year ago. Basic earnings per share from continuing operations was TWD 0.58 compared to TWD 0.38 a year ago. Diluted earnings per share from continuing operations was TWD 0.57 compared to TWD 0.38 a year ago.